SCHEMBL2828429

SCHEMBL2828429

CC(O)(c1cn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c2ccccc12)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA2 P47869 5/20 0.45
GABRB2 P47870 5/20 0.45
MAPT P10636 4/20 0.42
HPGD P15428 4/20 0.42
NPSR1 Q6W5P4 3/20 0.42
HTT P42858 2/20 0.42
ALDH1A1 P00352 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP2C9 P11712 4/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP19A1 P11511 3/20 0.40
CYP11B1 P15538 3/20 0.40
CYP11B2 P19099 3/20 0.40
RECQL P46063 1/20 0.40
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4411178 0.92 GABRA2 (0.44) GABRA2GABRB2MAPTHPGDNPSR1
SCHEMBL2829188 0.88 MAPT (0.42) GABRA2GABRB2MAPTHPGDNPSR1
SCHEMBL2831625 0.85 MAPT (0.42) GABRA2GABRB2MAPTHPGDNPSR1
SCHEMBL2831822 0.84 MAPT (0.61) MAPTHPGDNPSR1HTTALDH1A1
SCHEMBL2834112 0.83 GABRA2 (0.43) GABRA2GABRB2MAPTHPGDNPSR1
SCHEMBL980587 0.82 GABRA2 (0.40) GABRA2GABRB2MAPTHPGDNPSR1
SCHEMBL4415348 0.82 GABRA2 (0.40) GABRA2GABRB2CYP2C9CYP2C19CYP19A1
SCHEMBL2830711 0.81 HPGD (0.44) GABRA2GABRB2MAPTHPGDNPSR1
SCHEMBL13707233 0.79 NR4A2 (0.44) ALDH1A1CYP2C9KDM4ECYP19A1CYP11B1
SCHEMBL980011 0.79 GABRA2 (0.38) GABRA2GABRB2GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945611-B1 N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES NOVARTIS AG (CH) 2010-01-06 EP disclosed
US-20090227538-A1 N-(Hetero)Aryl Indole Derivatives as Pesticides NOVARTIS AG (CH) 2009-09-10 US disclosed
EP-1945611-A1 N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES Novartis Pharma AG (CH) 2008-07-23 EP disclosed
WO-2007051619-A1 N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES NOVARTIS AG (CH) 2007-05-10 WO disclosed
EP-1783114-A1 N-(hetero)aryl indole derivatives as pesticides Novartis AG (CH) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227538-A1 N-(Hetero)Aryl Indole Derivatives as Pesticides IDO1, IDO2, CHRM1 GABRA2 1275/4885GABRB2 1625/4885MAPT 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.